A pilot study of the effects of sildenafil on stool characteristics, colon transit, anal sphincter function, and rectal sensation in healthy men

Digestive Diseases and Sciences

Volumn 50, Issue 6, 2005, Pages 1005-1011

  Milone, Mark ^a   DiBaise, John K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Anal sphincter; Colon transit; Rectal sensation; Sildenafil

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; SILDENAFIL;

ADULT; ANORECTAL PRESSURE; ANUS SPHINCTER; ARTICLE; CLINICAL PATHWAY; COLON; CONTROLLED STUDY; DEFECATION; DRUG TOLERABILITY; DRUG USE; FECES ANALYSIS; FECES COMPOSITION; GASTROINTESTINAL TOXICITY; GASTROINTESTINAL TRACT FUNCTION; HUMAN; HUMAN EXPERIMENT; ILEUM; INTESTINE; INTESTINE TRANSIT TIME; MALE; MUSCLE FUNCTION; NORMAL HUMAN; PRIORITY JOURNAL; RECTUM; SENSATION; SMOOTH MUSCLE RELAXATION; STATISTICAL SIGNIFICANCE;

ADULT; ANAL CANAL; COLON; DEFECATION; FECES; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINE, LARGE; MALE; MANOMETRY; MIDDLE AGED; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PILOT PROJECTS; PIPERAZINES; RECTUM; SENSATION;

EID: 20844437092     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2695-5     Document Type: Article

References (42)

1. Shah V, Lyford G, Gores G, Farrugia G: Nitric oxide in gastrointestinal health and disease. Gastroenterology 126:903-913, 2004
2. Sanders, K, Ward S: Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Am J Physiol 262:G379-G392, 1992
3. Luo ZD, Cizkova D: The role of nitric oxide in nociception. Curr Rev Pain 4:459-466, 2000
4. Ahn HS, Foster M, Cable M, Pitts BJ, Sybertz EJ: Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues. Adv Exp Med Biol 308:191-197, 1991
5. Rhee PL, Hyun JG, Lee JH, et al.: The effect of sildenafil on lower esophageal sphincter and body motility in normal male adults. Am J Gastroenterol 96:3251-3257, 2001
6. Eherer AJ, Schwetz I, Hammer HF, Petnehazy T, Scheidl SJ, Weber K, Krejs GJ: Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 50:758-764, 2002
7. Zhang X, Tack J, Janssens J, Sifrim DA: Effect of sildenafil, a phospodiesterase-5 inhibitor, on oesophageal peristalsis and lower oesophageal sphincter function in cats. Neurogastroenterol Motil 13:325-331, 2001
8. Bortolotti M, Mari C, Lopilato C, Porrazzo G, Miglioli M: Effects of sildenafil on esophageal motility on patients with idiopathic achalasia. Gastroenterology 118:253-257, 2000
9. Bortolotti M, Mari C, Giovannini M, Pinna S, Miglioli M Effects of sildenafil on esophageal motility of normal subjects. Dig Dis Sci 46:2301-2306, 2001
10. Bortolotti M, Mari C, Lopilato C, La Rovere L, Miglioli M: Sildenafil inhibits gastroduodenal motility. Alimentary Pharmacol Ther 15:157-161, 2001
11. Rao SSC, Azpiroz F, Diamant N, Enck P, Tougas G, Wald A: Minimum standards of anorectal manometry. Neurogastroenterol Motil 14:553-559, 2002
12. Knowles JB, Whitehead WE, Meyer KB: Reliability of a modified sitzmark study of whole gut transit time. Gastroenterology 114:A779, 1998 (abstract)
13. Lewis SJ, Heaton KW: Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920-924, 1997
14. Jain NK, Patil CS, Singh A, Kulkarni SK: Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res 909:170-178, 2001
15. Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Grandos-Soto V: Sildenafil produces antinociception and increases morphine antinociception in the formalin test. Eur J Pharmacol 400:81-87, 2000
16. Chadker S, Bandyopadhyay A, Rattan S: Neuronal NOS gene expression in gastrointestinal myenteric neurons and smooth muscle cells. Am J Physiol 273:C1868-C1875, 1997
17. Suthamnatpong N, Hata F, Kanada A, Takeuchi T, Yagasaki O: Mediators of nonadrenergic, noncholinergic inhibition in the proximal, middle and distal regions of rat colon. Br J Pharmacol 108:348-355, 1993
18. Tam FS, Hillier K: The role of nitric oxide in mediating non-adrenergic non-cholinergic relaxation in longitudinal muscle of human taenia coli. Life Sci 51:1277-1284, 1992
19. Kamata K, Kohzuki M, Misawa M, Kasuya Y: Involvement of nitric oxide pathway in non-adrenergic non-cholinergic (NANC) relaxation in the rat stomach: Differential innervation of NANC nerves in the longitudinal and circular muscle of the fundus. Gen Pharmacol 24:1403-1410, 1993
20. Mizuta Y, Takahashi T, Owyang C: Nitrergic regulation of colonic transit in rats. Am J Physiol 277:G275-G279, 1999
21. Boeckxstaens GE, Pelckmans PA, Herman AG, Van Maercke YM: Involvement of nitric oxide in the inhibitory innervation of the human isolated colon. Gastroenterology 104:690-697, 1993
22. Nottrup A, Glavind EB, Svane D: Involvement of the L-arginine-nitric oxide pathway in internal anal sphincter relaxation. Gastroenterology 102:409-415, 1992
23. G-Nitro-L-arginine reduces nonadrenergic, non-cholinergic relaxations of human gut. Gastroenterology 102:679-683, 1992
24. Tomita R, Tanjoh K, Fujisaki S, Fukuzawa M: The role of nitric oxide (NO) in the human internal anal sphincter. J Gastroenterol 36:386-391, 2001
25. Fritz E, Hammer J, Schmidt B, Eherer AJ, Hammer HF: Stimulation of the nitric oxide-guanosine 3′, 5′ cyclic monophosphate pathway by sildenafil: Effect on rectal muscle tone, distensibility, and perception in health and in irritable bowel syndrome. Am J Gastroenterol 98:2253-2260, 2003
26. Hammer HF, Phillips SF, Camilleri M, Hanson RB: Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol 274:G584-G590, 1998
27. O'Kelly TJ, Brading AF, Mortensen NJ: Nerve mediated relaxation of the human internal anal sphincter: the role of nitric oxide. Gut 34:689-693, 1993
28. Stebbing JF: Nitric oxide synthase neurons and neuromuscular behaviour of the anorectum. Ann R Coll Surg Engl 80:137-145, 1998
29. Stebbing JF, Brading AF, Mortensen NJ: Nitric oxide and the rectoanal inhibitory reflex: retrograde neuronal tracing reveals a descending nitrergic rectoanal pathway in a guinea pig model. Br J Surg 83:493-498, 1996
30. Rattan S, Sarkar A, Chakder S: Nitric oxide pathway in rectoanal inhibitory reflex of opossum internal anal sphincter. Gastroenterology 103:43-50, 1992
31. Jones OM, Brading AF, Mortensen NJ: Phosphodiesterase inhibitors cause relaxation of the internal anal sphincter in vitro. Dis Colon Rectum 45:530-536, 2002
32. Stebbing JF, Brading AF, Mortensen NJ: Role of nitric oxide in relaxation of the longitudinal layer of rectal smooth muscle. Dis Colon Rectum 40:706-710, 1997
33. Jones OM, Mortensen NJ: Phosphodiesterase inhibitors cause relaxation of the internal anal sphincter in vitro. Dis Colon Rectum 45:530-536, 2002
34. Torrabadella L, Salgado G, Burns RW, Berman IR: Manometric study of topical sildenafil (Viagra) in patients with chronic anal fissure: sildenafil reduces anal resting tone. Dis Colon Rectum 47:733-738, 2004
35. Madoff R: Pharmacological therapy for anal fissure. N Engl J Med 338:257-259, 1998
36. Mourad FH, Turvill JL, Farthing MJ: Role of nitric oxide in intestinal water and electrolyte transport. Gut 44:143-147, 1999
37. Schirgi-Degen A, Beubler E: Proabsorptive properties of nitric oxide. Digestion 59:400-403, 1998
38. Chiba T, Bharucha AE, Thomforde GM, Kost LJ, Phillips SF: Model of rapid gastrointestinal transit in dogs: effects of muscarinic antagonists and a nitric oxide synthase inhibitor. Neurogastroenterol Motil 14:535-541, 2002
39. Mascolo N, Gaginella TS, Izzo AA, Di Carlo G, Capasso F: Nitric oxide involvement in sodium choleate-induced fluid secretion and diarrhea in rats. Eur J Pharmacol 264:21-26, 1994
40. Izzo AA, Gaginella TS, Mascolo N, Capasso F: Nitric oxide as a mediator of the laxative action of magnesium sulphate. Br J Pharmacol 113:228-232, 1994
41. Bharucha AE, Seide B, Fox JC, Zinsmeister AR: Day-to-day reproducibility of anorectal sensorimotor assessments in healthy subjects. Neurogastroenterol Motil 16:241-250, 2004
42. Seftel A: Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharmacokinetic, and efficacy profiles. Clin Cardiol 27:114-119, 2004